NCT03050749View on ClinicalTrials.gov

Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 20, 2016

Primary Completion Date

October 18, 2017

Study Completion Date

March 6, 2018

Conditions
Facial LipoatrophyMorphological Asymmetry of the FaceDebilitating Scars
Interventions
DEVICE

Princess® VOLUME

Princess® VOLUME injections up to 10 ml applied to the eligible subjects at the baseline visit, and the touch-up visit, if applicable.

Trial Locations (3)

Unknown

Medical University Graz, Graz

MÄZ WIEN Medizinisch Ästhetisches Zentrum Wien, Vienna

Ordination Dr. Benjamin Gehl, Vienna

Sponsors

Lead Sponsor

Croma-Pharma GmbH
All Listed Sponsors
lead

Croma-Pharma GmbH

INDUSTRY

NCT03050749 - Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars | Biotech Hunter | Biotech Hunter